South Dakota and a coalition of 48 states and territories announce settlements (Feb. 2, 2026) with Lannett Company, Inc. (“Lannett”) and Bausch Health US, LLC and Bausch Health Americas, Inc. (“Bausch”), totaling $17.85 million to resolve allegations that both companies engaged in widespread , long-running conspiracies to artificially inflate and manipulate prices, reduce competition, and unreasonably restrain trade with regard to numerous generic prescription drugs. Attorney General Marty Jackley also is part of another group of Attorneys General representing 42 states and territories who have filed a new lawsuit against Novartis and its generic subsidiary Sandoz alleging a systemic campaign to conspire with other generic manufacturers to fix prices, allocate markets and rig bids for 31 different generic drugs. Medications included in this settlement are: Lannett: Baclofen Tablets (Teva Complaint) Levothyroxine Sodium (Teva Complaint) Doxycycline Monohydrate (Heritage Complaint) Acetazolamide Tablets (Dermatology Complaint) Bausch: Latanoprost Drops (Dermatology Complaint) Fluocinonide 0.1% Cream (Dermatology Complaint) South Dakotans who purchased a generic prescription drug manufactured by either Lannett or Bausch between May 2009 and December 2019, may be eligible for compensation. To determine eligibility, call 1-866-290-0182 (Toll-Free), email [email protected] or visit www.AGGenericDrugs.com. Other states and territories settling with Lannett and Bausch include: Alaska, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Northern Mariana Islands, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Utah, U.S. Virgin Islands, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming, and Puerto Rico. South Dakota is joined in filing the new complaint against Novartis and Sandoz with the Attorneys General of Alaska, Arizona, California, Connecticut, Colorado, Delaware, District of Columbia, Idaho, Illinois, Indiana, Iowa, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Northern Mariana Islands, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, Tennessee, Vermont, U.S. Virgin Islands, Virginia, Washington, West Viginia, Wisconsin, and Wyoming.   ...read more read less